Translating passion into execution: Cure Rare Disease's founder on the business of biotech
When a career path chooses you in the form of a pressing personal cause, passion and commitment must soon be followed by execution. And that means schooling up — quickly. I had heard the call of entrepreneurship early. I had a new Harvard Business School degree in hand at the same time my brother’s health was declining steeply due to Duchenne muscular dystrophy. His fatal degenerative neuromuscular condition wouldn't wait, and the lack of viable option s in the pipeline for his gene mutation required entrepreneurial thinking. The science would come. I was in Boston, after all, immersed in bioscience. And it has.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Rich Horgan Source Type: news
More News: Biotechnology | Brain | Genetics | Harvard | Health Management | Muscular Dystrophy | Neurology | Neuroscience | Rare Diseases | Reflex Sympathetic Dystrophy | Science